HUT65838A - Pharmateutical preparations containing tnf inhibitors - Google Patents

Pharmateutical preparations containing tnf inhibitors

Info

Publication number
HUT65838A
HUT65838A HU9301509A HU150993A HUT65838A HU T65838 A HUT65838 A HU T65838A HU 9301509 A HU9301509 A HU 9301509A HU 150993 A HU150993 A HU 150993A HU T65838 A HUT65838 A HU T65838A
Authority
HU
Hungary
Prior art keywords
pharmateutical
preparations containing
tnf inhibitors
containing tnf
inhibitors
Prior art date
Application number
HU9301509A
Other languages
Hungarian (hu)
Other versions
HU9301509D0 (en
Inventor
Klaus Max Esser
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HU9301509D0 publication Critical patent/HU9301509D0/en
Publication of HUT65838A publication Critical patent/HUT65838A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • AIDS & HIV (AREA)
  • Agronomy & Crop Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9301509A 1990-11-21 1991-11-20 Pharmateutical preparations containing tnf inhibitors HUT65838A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61647990A 1990-11-21 1990-11-21

Publications (2)

Publication Number Publication Date
HU9301509D0 HU9301509D0 (en) 1993-11-29
HUT65838A true HUT65838A (en) 1994-07-28

Family

ID=24469639

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9301509A HUT65838A (en) 1990-11-21 1991-11-20 Pharmateutical preparations containing tnf inhibitors

Country Status (14)

Country Link
EP (1) EP0558659A4 (en)
JP (1) JP3204971B2 (en)
KR (1) KR930702896A (en)
AP (1) AP259A (en)
AU (1) AU656938B2 (en)
CA (1) CA2096623A1 (en)
HU (1) HUT65838A (en)
IE (1) IE914034A1 (en)
IL (1) IL100088A (en)
MX (1) MX9102173A (en)
NZ (1) NZ240644A (en)
TW (1) TW222001B (en)
WO (1) WO1992009203A1 (en)
ZA (1) ZA919178B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
AU7376394A (en) * 1993-08-04 1995-02-28 Andrulis Pharmaceuticals Corporation Use of tumor necrosis factor inhibitors together with antiviral agents and therapeutic compositions thereof against hiv infection
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
US7608262B2 (en) * 1996-02-16 2009-10-27 The Kennedy Institute Of Rheumatology Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
GB9703044D0 (en) 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
WO2004047817A1 (en) * 2002-11-27 2004-06-10 Altana Pharma Ag Pde4 and pde3/4 inhibitors for use in the treatment of cachexia
BRPI0507604A (en) 2004-02-14 2007-07-03 Smithkline Beecham Corp medicines with hm74a receptor activity
JP2009504592A (en) 2005-08-10 2009-02-05 スミスクライン・ビーチャム・コーポレイション Xanthine derivatives as selective HM74A agonists
BR112017007194B1 (en) 2014-10-09 2023-11-07 Guangdong Raynovent Biotech Co., Ltd HYDROXYL PURINE COMPOUNDS AND USE THEREOF
WO2017071607A1 (en) * 2015-10-29 2017-05-04 南京明德新药研发股份有限公司 CRYSTAL FORM OF 4H-PYRAZOLO[1,5-α]BENZOIMIDAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND INTERMEDIATE THEREOF

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US757328A (en) * 1903-02-07 1904-04-12 Boehringer & Soehne Art of preparing xanthin derivatives.
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
CH654008A5 (en) * 1979-05-22 1986-01-31 Nestle Sa PROCESS FOR THE PREPARATION OF 1,3,7-TRIALKYLXANTHINES.
DE2944568A1 (en) * 1979-11-05 1981-05-14 Institut für industrielle Pharmazie F + E GmbH, 8750 Aschaffenburg Sodium 8-chloro-theophyllinate as immunostimulant - which selectively stimulates formation of IGM antibodies
IT1200944B (en) * 1982-08-10 1989-01-27 Malesci Sas XANTHINIC DERIVATIVES, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT AND THEIR THERAPEUTIC USE
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8610136D0 (en) * 1986-04-25 1986-05-29 Wellcome Found Compounds
IT1197516B (en) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa THEOFILLINMETYLANIC AND THEOFILLINMETYLDITIAN DERIVATIVES PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5015647A (en) * 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
DE3817955A1 (en) * 1988-05-27 1989-11-30 Hoechst Ag MEDICINAL PRODUCT CONTAINING TNF INHIBITOR
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
FI891419A (en) * 1989-03-23 1990-09-24 Tampella Oy Ab ANORDNING I EN GAENGOEPPNINGSANORDNING FOER BORRMASKINERI.

Also Published As

Publication number Publication date
JP3204971B2 (en) 2001-09-04
EP0558659A4 (en) 1993-10-20
AP259A (en) 1993-06-03
WO1992009203A1 (en) 1992-06-11
IL100088A (en) 1995-07-31
MX9102173A (en) 1992-06-01
AP9100335A0 (en) 1992-01-31
CA2096623A1 (en) 1992-05-22
IL100088A0 (en) 1992-08-18
HU9301509D0 (en) 1993-11-29
AU9115991A (en) 1992-06-25
KR930702896A (en) 1993-11-29
AU656938B2 (en) 1995-02-23
IE914034A1 (en) 1992-06-03
JPH06506192A (en) 1994-07-14
NZ240644A (en) 1994-08-26
TW222001B (en) 1994-04-01
EP0558659A1 (en) 1993-09-08
ZA919178B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
HU9302889D0 (en) Contrast-materials containing melani9n-derivatives
AU8292091A (en) Tnf inhibitors
HU911672D0 (en) Tfg-beta preparations
EP0582389A3 (en) Easel
EP0498622A3 (en) Liquid vaporizer-feeder
HUT65838A (en) Pharmateutical preparations containing tnf inhibitors
ZA897212B (en) (diarylmethoxy alkyl)-1-pyrrolidines and-piperidines
EP0496162A3 (en) Peptide inhibitors of ras-gap interaction
ZA931222B (en) TNF inhibitors
GB9122735D0 (en) Methods
GB9122721D0 (en) Methods
EP0525209A4 (en) Articulator
ZA916059B (en) Tnf inhibitors
GB9115260D0 (en) Receptacle
GB9201305D0 (en) Yieldable supports
GB2272370B (en) An easel
GB9026251D0 (en) Netalloproteinase inhibitors
IE882030L (en) Dopamine-beta-hydroxylase inhibitors
IE880860L (en) Dopamine-beta-hydroxylase inhibitors
ZA923124B (en) Wf11243 substance
BG95449A (en) Antiemmetic substance
IE893832L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
AU116119S (en) Easel
PHUM7761Z (en) Liquid dispenser-cooler
GB9113865D0 (en) Novel substance

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal